Physician profile
William W Hooper
NPI 1720052988
$6,963.08
in general payments reported to CMS, 2019-2025
43 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,336 · 2020: $1,382 · 2021: $1,237 · 2022: $632 · 2023: $696 · 2024: $497 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,310.42 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $1,120.26 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $637.67 | 2019-2023 | Tezspire, Tagrisso, Fasenra |
| Philips North America LLC | $431.39 | 2019-2023 | |
| Genzyme Corporation | $333.10 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $301.41 | 2019-2024 | Opsumit, Uptravi |
| Grifols USA, LLC | $237.84 | 2019-2025 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $214.31 | 2019-2021 | |
| Mylan Specialty L.P. | $191.68 | 2019-2024 | Yupelri |
| Allergan, INC. | $143.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $137.44 | 2019-2024 | Dupixent |
| Sunovion Pharmaceuticals INC. | $125.95 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $124.91 | 2021 | |
| Merck Sharp & Dohme LLC | $121.72 | 2019-2024 | Winrevair |
| Genentech USA, INC. | $118.28 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.